Stefan Doboczky
Director/Board Member at OMV AG
Profile
Stefan Doboczky is currently the Chief Executive Officer at Heubach GmbH since 2022.
He is also an Independent Member-Supervisory Board at OMV AG since 2019 and a Member-Supervisory Board at Singapore Economic Development Board.
Previously, Dr. Doboczky served as the Chief Executive Officer at Lenzing AG from 2015 to 2021.
Before that, he was the Director & Member-Management Board at DSM BV from 2011 to 2015.
He also held positions such as Business Director at DSM Pharma Chemicals Venlo BV in 2006, President & Director-Business Group at DSM Anti Infectives BV from 2009 to 2011, Vice President & Director-Business Unit at DSM Anti Infectives China from 2006 to 2009, and Manager-Business Pharma at DSM Fine Chemicals Austria Nfg GmbH & CoKG from 2000 to 2002.
Dr. Doboczky holds an MBA from the International Institute for Management Development and has graduate and doctorate degrees from Technische Universität Wien.
Stefan Doboczky active positions
Companies | Position | Start |
---|---|---|
OMV AG | Director/Board Member | 2019-05-13 |
Singapore Economic Development Board | Director/Board Member | - |
Heubach GmbH
Heubach GmbH Chemicals: SpecialtyProcess Industries Heubach GmbH produces and supplies corrosion protection pigments. Its products include coatings, plastics, inks, papers, seeds, viscose and latex. The company was founded in 1806 and is headquartered in Langelsheim, Germany. | Chief Executive Officer | 2022-01-09 |
Former positions of Stefan Doboczky
Companies | Position | End |
---|---|---|
LENZING AG | Chief Executive Officer | 2021-09-29 |
DSM NV
DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Director/Board Member | 2015-05-31 |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | President | 2010-12-31 |
DSM Anti Infectives China | Corporate Officer/Principal | 2008-12-31 |
DSM Pharma Chemicals Venlo BV | Corporate Officer/Principal | 2005-12-31 |
Training of Stefan Doboczky
International Institute for Management Development | Masters Business Admin |
Technische Universität Wien | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OMV AG | Energy Minerals |
LENZING AG | Process Industries |
Private companies | 7 |
---|---|
DSM NV
DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Process Industries |
Singapore Economic Development Board | Government |
Heubach GmbH
Heubach GmbH Chemicals: SpecialtyProcess Industries Heubach GmbH produces and supplies corrosion protection pigments. Its products include coatings, plastics, inks, papers, seeds, viscose and latex. The company was founded in 1806 and is headquartered in Langelsheim, Germany. | Process Industries |
DSM Fine Chemicals Austria Nfg GmbH & CoKG
DSM Fine Chemicals Austria Nfg GmbH & CoKG Medical DistributorsDistribution Services Part of DSM-Firmenich AG, DSM Fine Chemicals Austria Nfg GmbH & CoKG supplies chemical intermediaries for the pharmaceutical industry. The private company is based in Linz, Austria. | Distribution Services |
DSM Pharma Chemicals Venlo BV | |
DSM Anti Infectives China | |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM BV, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Health Technology |
- Stock Market
- Insiders
- Stefan Doboczky